- CMTA Appoints Biotech Industry Veteran Suzanne Bruhn, PhD as New CEO
GLENOLDEN, Pa., November 6, 2023 – The Charcot-Marie-Tooth Association announced Nov. 6 that Suzanne (Sue) Bruhn, PhD, an accomplished biotech executive with extensive experience in the development and commercialization of treatments for rare diseases, will ...
Read more ... - CMTA Funds Preclinical Work on Modulating Unfolded Protein Response in CMT1B Mice
The Charcot-Marie-Tooth (CMT) Association announced a $33,000 grant on April 25 that will enable Maurizio D’Antonio, PhD, to establish if molecules that selectively activate the ATF6 pathway of the Unfolded Protein Response (UPR) can engage ...
Read more ... - Vera Fridman, MD joins the CMTA STAR Advisory Board
In a suite of exciting appointments, the Charcot-Marie-Tooth Association (CMTA) Strategy to Accelerate Research (STAR) Advisory Board is delighted to announce the appointment of Dr. Vera Fridman to their Clinical Expert Board (CEB). The CEB ...
Read more ... - Bruce R Conklin, MD Joins the CMTA STAR Advisory Board
In a suite of exciting appointments, the Charcot-Marie-Tooth Association (CMTA) Strategy to Accelerate Research (STAR) Advisory Board is delighted to announce the appointment of Dr. Bruce Conklin to its Scientific Advisory Board (SAB). The SAB ...
Read more ... - Diana Bharucha-Goebel, MD Joins the CMTA-STAR Advisory Board
In a suite of exciting appointments, the Charcot-Marie-Tooth Association (CMTA) Strategy to Accelerate Research (STAR) Advisory Board is delighted to announce the appointment of Dr. Diana Bharucha-Goebel to their Clinical Expert Board (CEB). The CEB ...
Read more ...